QT Imaging Q1 Revenue Jumps 133% to $6.5M, Secures Key CPT Code & $24M+ UAE Deal
QTI has more than doubled off its 52-week low of $1.95 on elevated volume (3.1× avg).
Summary
QT Imaging Holdings reported robust first-quarter 2026 results, with revenue increasing 133% year-over-year to $6.5 million, driven by the shipment of 13 Breast Acoustic CT systems. Beyond the strong top-line growth, the company announced several highly material developments: securing a Category III CPT code (X579T) for its 3D quantitative transmission volumetric ultrasound tomography, effective January 2027, which is a critical step towards U.S. reimbursement. Furthermore, QT Imaging received regulatory clearance in the UAE and established a multi-year distribution agreement for 43 scanners, projected to generate over $24 million in revenue. The company also secured a two-year extension on its senior secured term loan, enhancing financial flexibility, and received FDA 510(k) clearance for scanner enhancements. These combined achievements signal significant commercialization progress, de-risking future revenue streams, and expanding the company's global footprint, making this a highly impactful update for traders.
At the time of this announcement, QTI was trading at $7.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $91.4M. The 52-week trading range was $1.95 to $9.21. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.